Major Announcement
GICI funds three new trials!! $50,000 has been awarded to Dr Roslyn Kemp of the University of Otago. In colorectal cancer, a strong immune response within the tumour is associated with a good outcome for patients. Dr Kemp will validate this finding, for the first time, in New Zealand patients. She will also use a new technology to characterize these immune cells to determine their mechanisms of action. This is vital research bringing colorectal cancer up to the latest in immunological responses. We look forward to the outcomes of this is major research!